OLIGONUCLEOTIC ANALOGUES TARGETING HUMAN LMNA

MA45616AUndetermined Publication Date: 2019-03-06SAREPTA THERAPEUTICS INC +3

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA45616
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2016-04-29
Filing Date: 2017-04-28
Publication Date: 2019-03-06

Application Information

Patent Timeline

29 Apr 2016

Priority

28 Apr 2017

Application

MA45616

06 Mar 2019

Publication

MA45616A

IPC: C12N15/113

CPC: A61P43/00; C07K7/06; C12N15/113; C12N2320/33; C12N2310/11; C12N2310/3513; C12N2310/351; C12N2310/3233

Inventors: BESTWICK Richard Keith; CAO Kan

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to lmna-targeted antisense oligonucleotides intended to reduce the expression of one or more aberrantly spliced lmna mRNA isoforms that encode progerin.

Need to check novelty before this filing date? Find Prior Art